1. Distinguishing septic shock from non-septic shock in postsurgical patients using gene expression
- Author
-
Emilio García-Morán, Marta Martín-Fernández, Marta Aragón-Camino, Esther Gómez-Sánchez, Estefanía Gómez-Pesquera, Pedro Martínez-Paz, Pilar Liu, Álvaro Tamayo-Velasco, Alejandra Fadrique-Fuentes, Christian Ortega-Loubon, María Heredia-Rodríguez, Eduardo Tamayo, Hugo Gonzalo-Benito, and Mario Lorenzo-López
- Subjects
0301 basic medicine ,Microbiology (medical) ,Secondary infection ,030106 microbiology ,Gene Expression ,Bioinformatics ,Procalcitonin ,Sepsis ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,030212 general & internal medicine ,Receiver operating characteristic ,Microarray analysis techniques ,business.industry ,Septic shock ,Reproducibility of Results ,medicine.disease ,Shock, Septic ,Gene expression profiling ,Infectious Diseases ,ROC Curve ,Shock (circulatory) ,medicine.symptom ,business ,Biomarkers - Abstract
Objectives To obtain a gene expression signature to distinguish between septic shock and non-septic shock in postoperative patients, since patients with both conditions show similar signs and symptoms. Methods Differentially expressed genes were selected by microarray analysis in the discovery cohort. These genes were evaluated by quantitative real time polymerase chain reactions in the validation cohort to determine their reliability and predictive capacity by receiver operating characteristic curve analysis. Results Differentially expressed genes selected were IGHG1, IL1R2, LCN2, LTF, MMP8, and OLFM4. The multivariate regression model for gene expression presented an area under the curve value of 0.922. These genes were able to discern between both shock conditions better than other biomarkers used for diagnosis of these conditions, such as procalcitonin (0.589), C-reactive protein (0.705), or neutrophils (0.605). Conclusions Gene expression patterns provided a robust tool to distinguish septic shock from non-septic shock postsurgical patients and shows the potential to provide an immediate and specific treatment, avoiding the unnecessary use of broad-spectrum antibiotics and the development of antimicrobial resistance, secondary infections and increase health care costs.
- Published
- 2020